1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid CancerHead and Neck Neoplasms, Neoplasms by Site, cancer, childhood malignant neoplasm, differentiated thyroid carcinoma, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland carcinoma, thyroid gland disorder, thyroid tumorRecruitingPhase 22025-11-14NCT05783323